Navigating bottlenecks in cell therapy manufacturing: A versatile and scalable platform solution

As cell therapies quickly advance from pre-clinical stage into clinical and commercial applications, the design and implementation of scalable manufacturing platform technologies continues to be a focus for the field. Despite the successful commercialization of several cell therapies, bottlenecks in manufacturing throughput and capacity continue to hinder patient access to these life-saving treatments.

This webinar will explore the current landscape and limitations of cell therapy manufacturing platforms and share insights into how to choose a technology platform that assures flexibility in process development and scalability for clinical and commercial success.

• Challenges and opportunities associated with current cell therapy manufacturing platforms
• The flexibility of translating CAR T manufacturing processes to the Lonza Cocoon^® Platform
• How to ensure process flexibility that enables rapid implementation of iterative manufacturing improvements

Peter Yates

Director, Product Management - Personalized Medicine, Lonza

Peter Yates is the Director of Product Management for Lonza’s Personalized Medicine Business Unit. Peter earned a doctorate in Microbiology and Molecular Immunology from the University of Southern California in 2013 where he studied epigenetic regulation of hematopoietic development. Joining Lonza in early 2021, Peter’s focus is on the continued development and advancement of the Cocoon® Platform, a closed and automated cell therapy manufacturing solution.

Watch now

SPEAKERS

Peter Yates

Director, Product Management - Personalized Medicine, Lonza

You might also like

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Emily Neil, Ariadna Pascual

27 June

in 62

Days

Register

Precision in production: optimizing monitoring and quality control for high-value plasmids

Oleksandr Karpenko

6 June

in 41

Days

Register

Advancing cell therapy: innovations in polymer-based encapsulation and delivery

Y Brudno, O Veiseh, M Delic-Schlumbohm et al.

5 June

in 40

Days

Register

Pure and simple: understanding LNP analytics for better mRNA-based drugs

Adam Crowe

29 May

in 33

Days

Register

Empowering patient care: in-process and quality control solutions for cellular therapies

Christin Tischner, Simon Lennartz

23 May

in 27

Days

Register